These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38664785)

  • 21. Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence-Based Data Analyses of a National Multicenter Prospective Registry.
    Fernández-Carballido C; Sanchez-Piedra C; Valls R; Garg K; Sánchez-Alonso F; Artigas L; Mas JM; Jovaní V; Manrique S; Campos C; Freire M; Martínez-González O; Castrejón I; Perella C; Coma M; van der Horst-Bruinsma IE
    Arthritis Care Res (Hoboken); 2023 Jan; 75(1):115-124. PubMed ID: 36278846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI.
    Marona J; Sepriano A; Rodrigues-Manica S; Pimentel-Santos F; Mourão AF; Gouveia N; Branco JC; Santos H; Vieira-Sousa E; Vinagre F; Tavares-Costa J; Rovisco J; Bernardes M; Madeira N; Cruz-Machado R; Roque R; Silva JL; Marques ML; Ferreira RM; Ramiro S
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 32144137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Methodologic Considerations for Longitudinal Observational Studies.
    Zhao SS; Yoshida K; Jones GT; Hughes DM; Tedeschi SK; Lyu H; Moots RJ; Solomon DH; Goodson NJ
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):591-599. PubMed ID: 30762311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.
    Nissen M; Delcoigne B; Di Giuseppe D; Jacobsson L; Hetland ML; Ciurea A; Nekvindova L; Iannone F; Akkoc N; Sokka-Isler T; Fagerli KM; Santos MJ; Codreanu C; Pombo-Suarez M; Rotar Z; Gudbjornsson B; van der Horst-Bruinsma I; Loft AG; Möller B; Mann H; Conti F; Yildirim Cetin G; Relas H; Michelsen B; Avila Ribeiro P; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson ÁJ; Askling J; Glintborg B; Lindström U
    Rheumatology (Oxford); 2022 Nov; 61(12):4741-4751. PubMed ID: 35323903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria.
    Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Kaufmann C; Rødevand E; Mikkelsen K; Kalstad S; Kvien TK
    Rheumatology (Oxford); 2012 Aug; 51(8):1479-83. PubMed ID: 22499062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatigue in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Analysis from a Longitudinal Observation Cohort.
    Bedaiwi M; Sari I; Thavaneswaran A; Ayearst R; Haroon N; Inman RD
    J Rheumatol; 2015 Dec; 42(12):2354-60. PubMed ID: 26523020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?
    Manica SR; Sepriano A; Pimentel-Santos F; Gouveia N; Barcelos A; Branco JC; Bernardes M; Ferreira RM; Vieira-Sousa E; Barreira S; Vinagre F; Roque R; Santos H; Madeira N; Rovisco J; Daniel A; Ramiro S
    Arthritis Res Ther; 2020 Aug; 22(1):195. PubMed ID: 32825839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?
    Maksymowych WP; Inman RD; Bessette L; Rahman P; Rampakakis E; Asin-Milan O; Rachich M; Marrache AM; Lehman AJ
    Arthritis Res Ther; 2023 Apr; 25(1):70. PubMed ID: 37118833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
    Ørnbjerg LM; Rugbjerg K; Georgiadis S; Rasmussen SH; Lindström U; Pavelka K; Yilmaz N; Favalli EG; Nissen MJ; Michelsen B; Vieira-Sousa E; Jones GT; Ionescu R; Relas H; Sanchez-Piedra C; Tomšič M; Geirsson AJ; van der Horst-Bruinsma I; Askling J; Loft AG; Nekvindova L; Direskeneli H; Iannone F; Ciurea A; Fagerli KM; Santos MJ; Macfarlane GJ; Codreanu C; Eklund K; Pombo-Suarez M; Rotar Z; Gudbjornsson B; Rusman T; Østergaard M; Hetland ML
    J Rheumatol; 2023 Aug; 50(8):1009-1019. PubMed ID: 36455943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort.
    Hebeisen M; Neuenschwander R; Scherer A; Exer P; Weber U; Tamborrini G; Micheroli R; Wildi LM; Zufferey P; Nissen MJ; Villiger PM; Bernhard J; Finckh A; van der Horst-Bruinsma IE; Sieper J; Landewé R; van der Heijde D; Ciurea A;
    J Rheumatol; 2018 Apr; 45(4):506-512. PubMed ID: 29449504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
    Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
    Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective study.
    Vidal C; Lukas C; Combe B; Berenbaum F; Pers YM; Jorgensen C; Sellam J; Morel J
    Joint Bone Spine; 2018 Jul; 85(4):461-468. PubMed ID: 28917996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of remission in people with axial spondyloarthritis: A systematic literature review.
    Pinto AS; Farisogullari B; Machado PM
    Semin Arthritis Rheum; 2022 Oct; 56():152078. PubMed ID: 35944350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world evidence of TNF inhibition in axial spondyloarthritis: can we generalise the results from clinical trials?
    Jones GT; Dean LE; Pathan E; Hollick RJ; Macfarlane GJ
    Ann Rheum Dis; 2020 Jul; 79(7):914-919. PubMed ID: 32327428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
    Christiansen SN; Horskjær Rasmussen S; Ostergaard M; Pons M; Michelsen B; Pavelka K; Codreanu C; Ciurea A; Glintborg B; Santos MJ; Sari I; Rotar Z; Gudbjornsson B; Macfarlane GJ; Relas H; Iannone F; Laas K; Wallman JK; van de Sande M; Provan SA; Castrejon I; Zavada J; Mogosan C; Nissen MJ; Loft AG; Barcelos A; Erez Y; Pirkmajer KP; Grondal G; Jones GT; Hokkanen AM; Chimenti MS; Vorobjov S; Di Giuseppe D; Kvien TK; Otero-Varela L; van der Horst-Bruinsma I; Hetland ML; Ørnbjerg LM
    RMD Open; 2024 Jul; 10(3):. PubMed ID: 39053949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort.
    Pina Vegas L; Sbidian E; Wendling D; Goupille P; Ferkal S; Le Corvoisier P; Ghaleh B; Luciani A; Claudepierre P
    Rheumatology (Oxford); 2022 Apr; 61(4):1487-1495. PubMed ID: 34270707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equivalent cut-off values of Bath Ankylosing Spondylitis Disease Activity Index corresponding to Ankylosing Spondylitis Disease Activity Score cut-off values.
    Cui R; Du Y; Tian N; Jiang HL; Tao YL; Dai SM
    Clin Exp Rheumatol; 2023 May; 41(5):1163-1169. PubMed ID: 36226617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis.
    Lubrano E; Perrotta FM; Manara M; D'Angelo S; Addimanda O; Ramonda R; Punzi L; Olivieri I; Salvarani C; Marchesoni A
    J Rheumatol; 2018 Feb; 45(2):195-201. PubMed ID: 29419448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
    Kilic G; Kilic E; Ozgocmen S
    Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.